非酒精性脂肪性肝炎代谢机制的见解及其在治疗中的应用。
Insights Into Metabolic Mechanisms and Their Application in the Treatment of NASH.
作者信息
White Phillip J, Abdelmalek Manal F
机构信息
Division of Endocrinology, Metabolism and Nutrition and Duke Molecular Physiology Institute Department of Medicine Duke University Durham NC.
Division of Gastroenterology and Hepatology Department of Medicine Duke University Durham NC.
出版信息
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):29-32. doi: 10.1002/cld.1062. eCollection 2021 Jan.
Abstract
Watch a video presentation of this article Answer questions and earn CME.
摘要
观看本文的视频演示。回答问题并获得继续医学教育学分。
相似文献
1
Insights Into Metabolic Mechanisms and Their Application in the Treatment of NASH.非酒精性脂肪性肝炎代谢机制的见解及其在治疗中的应用。
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):29-32. doi: 10.1002/cld.1062. eCollection 2021 Jan.
2
Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer.将非酒精性脂肪性肝炎与癌症联系起来的分子机制
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):6-10. doi: 10.1002/cld.1006. eCollection 2021 Jan.
3
Pediatric Cholestasis: Epidemiology, Genetics, Diagnosis, and Current Management.小儿胆汁淤积症：流行病学、遗传学、诊断及当前治疗方法
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):115-119. doi: 10.1002/cld.895. eCollection 2020 Mar.
4
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.非酒精性脂肪性肝病与心血管疾病
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):19-22. doi: 10.1002/cld.1017. eCollection 2021 Jan.
5
Management of Hepatitis C-Infected Patients After Sustained Virological Response.丙型肝炎感染患者持续病毒学应答后的管理
Clin Liver Dis (Hoboken). 2020 Jul 21;16(1):20-24. doi: 10.1002/cld.913. eCollection 2020 Jul.
6
Isolated Elevated Bilirubin.孤立性胆红素升高
Clin Liver Dis (Hoboken). 2020 May 7;15(4):153-156. doi: 10.1002/cld.944. eCollection 2020 Apr.
7
Managing the Symptoms and Complications of Cholestasis.胆汁淤积症状及并发症的管理
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):120-124. doi: 10.1002/cld.901. eCollection 2020 Mar.
8
The Pathophysiology of Cholestasis and Its Relevance to Clinical Practice.胆汁淤积的病理生理学及其与临床实践的相关性。
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):110-114. doi: 10.1002/cld.894. eCollection 2020 Mar.
9
Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines.乙型肝炎病毒再激活：临床指南综述
Clin Liver Dis (Hoboken). 2020 May 7;15(4):162-167. doi: 10.1002/cld.883. eCollection 2020 Apr.
10
Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝纤维化评估中非侵入性方法的应用与局限性
Clin Liver Dis (Hoboken). 2020 May 7;15(4):157-161. doi: 10.1002/cld.878. eCollection 2020 Apr.
引用本文的文献
1
Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity.严重肥胖个体的非酒精性脂肪性肝病（NAFLD）具有支链α-酮酸代谢改变的特征。
JCI Insight. 2022 Aug 8;7(15):e159204. doi: 10.1172/jci.insight.159204.
2
The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC).非酒精性脂肪性肝病（NAFLD）与肝外癌症（EHC）之间令人不安的联系。
Cureus. 2021 Aug 20;13(8):e17320. doi: 10.7759/cureus.17320. eCollection 2021 Aug.
3
Novel Thienopyrimidines as Acetyl-CoA Carboxylase Inhibitors for Treating Liver Diseases.新型噻吩并嘧啶类化合物作为治疗肝脏疾病的乙酰辅酶A羧化酶抑制剂
ACS Med Chem Lett. 2021 Apr 27;12(5):694-695. doi: 10.1021/acsmedchemlett.1c00208. eCollection 2021 May 13.
本文引用的文献
1
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.乙酰辅酶 A 羧化酶抑制破坏肝星状细胞激活过程中的代谢重编程。
J Hepatol. 2020 Oct;73(4):896-905. doi: 10.1016/j.jhep.2020.04.037. Epub 2020 May 4.
2
Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent.非酒精性脂肪肝患者的血浆支链氨基酸变化具有性别依赖性。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa175.
3
Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes.ABHD5 与 PNPLA3 的动态相互作用调节棕色脂肪细胞中的三酰基甘油代谢。
Nat Metab. 2019 May;1(5):560-569. doi: 10.1038/s42255-019-0066-3. Epub 2019 May 6.
4
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis.载脂蛋白 PNPLA3 在脂滴上的积累是相关肝脂肪变性的基础。
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9521-9526. doi: 10.1073/pnas.1901974116. Epub 2019 Apr 24.
5
Mechanisms of NAFLD development and therapeutic strategies.非酒精性脂肪性肝病发病机制及治疗策略。
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
6
The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase.BCKDH 激酶和磷酸酶通过调节 ATP-柠檬酸裂解酶整合支链氨基酸和脂质代谢。
Cell Metab. 2018 Jun 5;27(6):1281-1293.e7. doi: 10.1016/j.cmet.2018.04.015. Epub 2018 May 17.
7
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.乙酰辅酶A羧化酶抑制可减轻小鼠和人类的肝脏脂肪变性，但会升高血浆甘油三酯水平：一项从床边到实验室的研究。
Cell Metab. 2017 Aug 1;26(2):394-406.e6. doi: 10.1016/j.cmet.2017.07.009.
8
A guide to immunometabolism for immunologists.免疫学家的免疫代谢指南。
Nat Rev Immunol. 2016 Sep;16(9):553-65. doi: 10.1038/nri.2016.70. Epub 2016 Jul 11.
9
Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.肝内脂肪生成增加是非酒精性脂肪性肝病患者的一个显著特征。
Gastroenterology. 2014 Mar;146(3):726-35. doi: 10.1053/j.gastro.2013.11.049. Epub 2013 Dec 4.
10
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.Acc1 和 Acc2 中的单一磷酸化位点调节脂质稳态和二甲双胍的胰岛素增敏作用。
Nat Med. 2013 Dec;19(12):1649-54. doi: 10.1038/nm.3372. Epub 2013 Nov 3.
Zotero 插件